10 surprising ways diabetes and dementia are connected

People with diabetes are approximately 60% more likely to develop dementia than those without the condition, according to recent research. This link involves insulin resistance in the brain and blood vessel damage, though certain diabetes medications—specifically SGLT2 inhibitors and GLP-1 agonists—may reduce the risk of cognitive decline.

Why does diabetes increase dementia risk?

Diabetes damages blood vessels, which leads to complications in the heart, kidneys, and eyes. Research indicates the brain is also at risk, as varying blood glucose levels can injure cerebral vessels, reducing oxygen delivery and blood flow.

This vascular damage can weaken the brain’s protective barrier. According to the research, this allows harmful substances to enter, causing inflammation that is strongly linked to dementia. Additionally, frequent episodes of low blood sugar are associated with a 50% higher chance of cognitive decline.

Did You Know? Memantine, a medication used to treat moderate to severe Alzheimer’s symptoms, was originally developed as a diabetes drug before researchers discovered its benefits for brain function.

What is the connection between insulin and the brain?

The brain represents only 2% of total body weight but consumes about 20% of the body’s energy. Insulin resistance, the primary cause of type 2 diabetes, occurs when cells stop responding to insulin, leaving too much glucose in the blood.

In Alzheimer’s patients, this resistance may prevent brain cells from using glucose for energy. This combination of insulin resistance and poor glucose utilization is sometimes unofficially referred to as “type 3 diabetes.”

The relationship is bidirectional. People with Alzheimer’s often exhibit higher fasting blood glucose, a form of pre-diabetes. Research into the APOE4 genetic variant, the highest genetic risk factor for Alzheimer’s, shows it reduces insulin sensitivity by trapping the insulin receptor inside the cell.

How do diabetes medications protect brain health?

Several classes of diabetes drugs show potential in preserving cognitive function. Metformin, the most common diabetes medication, may lower brain inflammation. Some studies suggest patients taking metformin are less likely to develop dementia, while those who stop the medication may see their risk increase.

🚨 LEAKED Houston Texans 2026 Schedule, Opponents & Instant Analysis | NFL Schedule Release

GLP-1 receptor agonist drugs, including semaglutide (Ozempic, Wegovy), have proven more effective than metformin at reducing dementia risk. SGLT2 inhibitors, which remove sugar through urine, may be even more superior than GLP-1 agonists in reducing the risk of vascular dementia and Alzheimer’s in people with type 2 diabetes.

Expert Insight: Samantha Carter notes that the development of 13 different classes of diabetes drugs and over 50 different medicines provides a massive toolkit for clinicians. The ability of these drugs to reduce inflammation and improve insulin sensitivity suggests that preserving brain health may be a significant secondary benefit of modern diabetes care.

What happens next in diabetes and dementia research?

Researchers are currently testing whether these medications can protect people who do not have diabetes. Two major trials, Evoke and Evoke Plus, are testing oral semaglutide in individuals with early mild Alzheimer’s or mild cognitive impairment.

Other experimental treatments include nasal insulin sprays. These are designed to deliver insulin directly to the brain to bypass blood sugar effects. While small studies suggest these sprays could reduce brain shrinkage or help memory, long-term safety and delivery consistency remain challenges.

Frequently Asked Questions

Does diabetes always lead to dementia?
No, but people with diabetes are about 60% more likely to develop dementia than those without it.

Which diabetes drug is most effective for dementia risk?
New evidence suggests SGLT2 inhibitors may be superior to GLP-1 receptor agonists in reducing dementia risk for people with type 2 diabetes.

What is “type 3 diabetes”?
It is an unofficial term used to describe the mix of insulin resistance and the inability of brain cells to properly use glucose in dementia patients.

How do you think these medical advancements will change the way we approach aging and brain health?